天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Hormones and the Endocrine System>Pancreatic hormone and blood sugar regulation>Tofogliflozin (hydrate)
Tofogliflozin (hydrate)
  • Tofogliflozin (hydrate)

Tofogliflozin (hydrate) NEW

Price $38 $54 $89
Package 1mg 2mg 5mg
Min. Order:
Supply Ability: 10g
Update Time: 2024-11-19

Product Details

Product Name: Tofogliflozin (hydrate) CAS No.: 1201913-82-7
Purity: 98.78% Supply Ability: 10g
Release date: 2024/11/19

Product Introduction

Bioactivity

NameTofogliflozin (hydrate)
DescriptionTofogliflozin hydrate (CSG-452 hydrate) is a potent and highly specific inhibitor of SGLT2, with an IC50 of 2.9 nM and Ki values of 2.9 nM, 14.9 nM, and 6.4 nM for human, rat, and mouse SGLT2, respectively.
In vitroTofogliflozin, a highly selective inhibitor of SGLT2 on oxidative stress generation, inflammatory and proapoptotic reactions in cultured human proximal tubular cells exposed to high glucose.?Tofogliflozin dose-dependently suppressed glucose entry into tubular cells.?High glucose exposure (30 mM) for 4 and 24 h significantly increased oxidative stress generation in tubular cells, which were suppressed by the treatment of tofogliflozin or an antioxidant N-acetylcysteine (NAC).?Monocyte chemoattractant protein-1 (MCP-1) gene expression and apoptotic cell death were induced by 4 h- and 8 day-exposure to high glucose, respectively, both of which were also blocked by tofogliflozin or NAC.?The present study suggests that SGLT2-mediated glucose entry into tubular cells could stimulate oxidative stress and evoke inflammatory and proapoptotic reactions in this cell type.?Blockade of glucose reabsorption in tubular cells by SGLT2 inhibitor might exert beneficial effects on tubulointerstitial damage in diabetic nephropathy[1].
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility InformationH2O : 0.33 mg/mL (0.82 mM), Sonication is recommended.
DMSO : 90 mg/mL (222.52 mM)
KeywordsTofogliflozin Hydrate | inhibit | CSG 452 Hydrate | CSG 452 | CSG452 | Reactive Oxygen Species | Tofogliflozin (hydrate) | CSG-452 | CSG452 Hydrate | Sodium-dependent glucose cotransporters | CSG-452 Hydrate | SGLT | Tofogliflozin | Inhibitor
Inhibitors RelatedImeglimin hydrochloride | Acetylcysteine | L-Ascorbic acid
Related Compound LibrariesHighly Selective Inhibitor Library | Bioactive Compound Library | Anti-Neurodegenerative Disease Compound Library | Membrane Protein-targeted Compound Library | Drug Repurposing Compound Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Drug Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/1g
VIP1Y
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
2024-12-25
$0.00/1G
VIP3Y
Changsha Staherb Natural Ingredients Co., Ltd.
2022-09-01
$10.00/25Kg/Drum
VIP5Y
Hebei Yanxi Chemical Co., Ltd.
2020-07-22
$216.00/5mg
Qiuxian Baitai New Material Co., LTD
2021-12-03
$2.00/1KG
VIP6Y
Career Henan Chemical Co
2019-12-20
  • Since: 2011-01-07
  • Address: 36?Washington?Street, Wellesley?Hills
INQUIRY